The model — developed by researchers from the U.S., Australia and Canada — projected vaping’s impact on public health by assessing the influence e-cigarettes have on traditional smoking patterns. The model predicted e-cigarette use can lead to a 21 percent decrease in deaths attributable to smoking and 20 percent reduction in years of life lost in people born in 1997 or after, compared to a scenario in which e-cigarettes were not an option for those seeking nicotine.
“Our model is consistent with recent evidence that, while e-cigarette use has markedly increased, cigarette smoking among youth and young adults has fallen dramatically,” said David Levy, PhD, a professor of oncology at Georgetown Lombardi Comprehensive Cancer Center in Washington and the study’s lead author. “Our study indicates that, considering a broad range of reasonable scenarios, e-cigarettes are likely to reduce cigarette smoking and not lead to offsetting increases in harm from the use of e-cigarettes and more deadly cigarettes…vaping is likely to have a net positive public health impact.”
More articles on population health:
Apartment complex residents at higher risk of secondhand smoke
New diabetes screening guidelines may miss half of patients
Third of working Americans say their jobs don’t offer paid sick days
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
